Guardion Health Sciences, Inc GHSI

Guardion Health Sciences, Inc NASDAQ
Upcoming Earnings
Market Cap
Div Yield
Upcoming Earnings
Market Cap
Div Yield

GHSI Stock Chart

Trade GHSI with trusted brokers on TradingView Open account
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM


Sector: Health Services
Industry: Medical/Nursing Services
Guardion Health Sciences, a clinical nutrition and diagnostics company, which develops medical foods and medical devices in the ocular health space and develops nutraceutical products to provide supportive health benefits to consumers. The firm operates through the following segments Medical Foods and Nutraceuticals & Medical Devices. The Medical Devices segment includes a portfolio of medical diagnostic devices currently focused on the ocular space and contrast testing. The Medical Foods and Nutraceuticals segment provides a portfolio of science-based, clinically supported nutrition, medical foods, and supplements. Its products include Lumega-Z, GlaucoCetin, ImmuneSF, VectorVision, and MapcatSF. The company was founded by Michael Favish in 2009 and is headquartered in San Diego, CA.